![]() |
市场调查报告书
商品编码
1468184
2024-2032 年按类型、应用、最终用户和地区分類的人工心肺机市场报告Artificial Heart-Lung Machine Market Report by Type, Application, End User, and Region 2024-2032 |
IMARC Group年,全球人工心肺机市场规模达到2.932亿美元。
人工心肺机,也称为心肺旁路 (CPB) 或氧合器泵,用于冠状动脉绕道、心臟和肺移植以及其他心臟手术。它暂时执行心臟和肺的功能,使外科医生能够在运动和无血的手术野中进行手术。这些机器由一个接收血液的腔室组成,然后血液被充氧并循环到身体的所有部位。多年来,这些帮浦在严重呼吸衰竭的治疗以及心臟手术领域取得了重大进展。
近年来,全球心臟直视手术、心臟移植和肺部手术的数量显着增加。这主要归因于各种环境和生活方式的变化,导致心血管疾病和器官衰竭的盛行率增加。除此之外,一些发展中国家的政府正在努力为病患提供更好的医疗设施,这推动了对人工心肺机的需求。此外,市场参与者正在投资研发活动,以使现有的充氧帮浦型号现代化。这些活动促进了模组化心肺机的开发,这些机器本质上具有成本效益、安全且用户友好。除此之外,这些机器还为医生提供了灵活性,因为它们便于携带并且可以使用可充电电池进行操作。製造商也对 CPB 帮浦进行了多项改进,以防止血液过度氧合。
The global artificial heart-lung machine market size reached US$ 293.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 393.7 Million by 2032, exhibiting a growth rate (CAGR) of 3.2% during 2024-2032.
An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs to enable the surgeon to operate in motion and bloodless surgical field. These machines consist of a chamber that receives blood, which is then oxygenated and circulated to all body parts. Over the years, these pumps have helped in making significant advances in the management of severe respiratory failure as well as in the field of car-diac surgeries.
In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures. Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines. Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial heart-lung machine market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on type, application and end user.
Single Roller Pump
Double Roller Pump
Cardiac Surgeries
Lung Surgeries
Acute Respiratory Failure Treatment
Others
Hospitals and Clinics
Ambulatory Surgical Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.